InsiderTrades

Form 4 for EQH Equitable Holdings, Inc.

Accepted 2025-03-17 00:00:00 ET · period of report 2025-03-14 · accession 0001628280-25-013287 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-17 2025-03-14 EQH Lane Nick See Remarks M - OptEx $23.18 +5,000 144.1K +4% +$115.9K
DM 2025-03-17 2025-03-14 EQH Lane Nick See Remarks S - Sale+OE $51.12 -5,000 140.8K -3% -$255.6K
D 2025-03-17 2025-03-14 EQH Lane Nick See Remarks M - OptEx $0.00 -5,000 64.4K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-14 M A 5,000 $23.18 144,072.87 D — — (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. (F2) Total includes Restricted Stock Units.
2 Common Common Stock 2025-03-14 S D 1,731 $51.34 139,072.87 D — — (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. (F4) This transaction was executed in multiple trades at prices ranging from $51.2900 to $51.4200. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes toprovide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units.
3 Common Common Stock 2025-03-14 S D 3,269 $51.01 140,803.87 D — — (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. (F3) This transaction was executed in multiple trades at prices ranging from $50.2800 to $51.2700. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units.
4 Derivative Employee Stock Option (right to buy) 2025-03-14 M D 5,000 $0.00 64,417 D $23.18 · — to 2030-02-26 5,000 Common Stock (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. (F5) Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.